Cargando…

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss

The rapid rise of obesity and type 2 diabetes poses a global threat to healthcare and is a major cause of mortality and morbidity. Bariatric surgery has revolutionised the treatment of both these conditions but is invasive and associated with an increased risk of complications. The EndoBarrier is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruban, Aruchuna, Ashrafian, Hutan, Teare, Julian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083488/ https://www.ncbi.nlm.nih.gov/pubmed/30147720 http://dx.doi.org/10.1155/2018/7823182

Ejemplares similares

EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
por: Patel, Nisha, et al.
Publicado: (2018)

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
por: Ryder, Robert E. J., et al.
Publicado: (2022)

A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
por: Glaysher, Michael Alan, et al.
Publicado: (2017)

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial
por: Ruban, Aruchuna, et al.
Publicado: (2022)

Effectiveness of different recruitment strategies in an RCT of a surgical device: experience from the Endobarrier trial
por: Ruban, Aruchuna, et al.
Publicado: (2019)

Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner
por: Aldhwayan, Madhawi M., et al.
Publicado: (2022)

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies
por: Rohde, Ulrich, et al.
Publicado: (2013)

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
por: Betzel, B., et al.
Publicado: (2019)

Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
por: Chen, Ji-Hua, et al.
Publicado: (2022)

Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels
por: Koehestanie, Parweez, et al.
Publicado: (2014)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021)

A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease
por: Ghoz, Hassan, et al.
Publicado: (2020)

Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis
por: Karlas, Thomas, et al.
Publicado: (2022)

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
por: van Rijn, Selwyn, et al.
Publicado: (2017)

Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
por: Boonchaya‐anant, Patchaya, et al.
Publicado: (2022)

Concurrent Placements of a Duodenal-Jejunal Bypass Liner and an Intragastric Balloon Among Severely Obese Patients: A Case Series
por: Sartoretto, Adrian, et al.
Publicado: (2019)

Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure
por: Hollenbach, Marcus, et al.
Publicado: (2018)

Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial
por: Tripolt, Norbert Joachim, et al.
Publicado: (2018)

Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
por: Okikawa, Shohei, et al.
Publicado: (2023)

Medical Devices in Obesity Treatment
por: Ruban, Aruchuna, et al.
Publicado: (2019)

Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
por: Balint, Istvan Bence, et al.
Publicado: (2021)

Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice
por: Liang, Yongjun, et al.
Publicado: (2017)

Diagnostic accuracy of i-scan image enhancement for real-time endoscopic diagnosis of small colorectal polyps: a meta-analysis
por: Glover, Ben, et al.
Publicado: (2018)

The endoscopic predictors of Helicobacter pylori status: a meta-analysis of diagnostic performance
por: Glover, Ben, et al.
Publicado: (2020)

Haemolytic uraemic syndrome - a rare case report of bloody diarrhoea in adults
por: Radhakrishnan, Shiva Thambiah, et al.
Publicado: (2019)

Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse
por: Barataud, Aude, et al.
Publicado: (2017)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

DUODENAL-JEJUNAL BYPASS REDUCES LIPID ACCUMULATION IN THE BROWN ADIPOSE TISSUE OF HYPOTHALAMIC OBESE RATS
por: CEGLAREK, Vanessa Marieli, et al.
Publicado: (2020)

Diagnostic Accuracy of Artificial Intelligence and Computer-Aided Diagnosis for the Detection and Characterization of Colorectal Polyps: Systematic Review and Meta-analysis
por: Nazarian, Scarlet, et al.
Publicado: (2021)

Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
por: Donglei, Zhou, et al.
Publicado: (2012)

Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial
por: Petry, Tarissa Z., et al.
Publicado: (2015)

Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats
por: Han, Hai-Feng, et al.
Publicado: (2022)

Conversion of Roux-en-Y gastric bypass to single anastomosis duodenal ileal bypass with sleeve gastrectomy with gastrogastric jejunal bridge
por: Dib, Victor Ramos Mussa, et al.
Publicado: (2022)

Duodenal-Jejunal Bypass Surgery Stimulates the Expressions of Hepatic Sirtuin1 and 3 and Hypothalamic Sirtuin1
por: Ha, Eunyoung, et al.
Publicado: (2018)

Duodenal and jejunal Dieulafoy’s lesions: optimal management
por: Yılmaz, Tonguç Utku, et al.
Publicado: (2017)

Proximal jejunal stoma as ultima ratio in case of traumatic distal duodenal perforation facilitating successful EndoVAC(®) treatment: A case report
por: Kelm, M., et al.
Publicado: (2017)

miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal–jejunal bypass
por: Guo, W, et al.
Publicado: (2016)

Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats
por: Cantelli, K.R., et al.
Publicado: (2017)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0qvhhghk8s4bj8fab43gg5a23g